Nov 23 2013
The spin-off from Joseph Fourier University, Grenoble (UJF), starts its incubation period accompanied by Grenoble’s innovation accelerators, Gravit and GATE1. Based on research by its leader, Prof. Jean Viallet (Associate Professor at UJF), the team intends to develop very promising in vivo assays for drug development, particularly for cancer treatments
Nov 8-12
2022
INOVOTION NEW POSTER IN COLLABORATION WITH BRENUS PHARMA PRESENTED AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC)’S 37TH ANNUAL MEETING, NOV 10-12TH IN BOSTON.
Jean Viallet (CEO/CSO) will present our poster (#949) on Nov 11th: “INNOVATIVE IN VIVO CAM MODEL TO PREDICT EFFICACY AND MODES OF ACTION OF NEW ANTITUMOR VACCINE STC-1010 ON HUMAN COLORECTAL ADENOCARCINOMA”. This poster […]
Oct 24-26
2022
Meet INOVOTION at BioEurope, Leipzig, Oct. 24-26
INOVOTION will attend BioEurope, Oct 24–26, 2022 in Leipzig. This will be a fantastic opportunity to initiate new contacts interested in improving and securing their preclinical pipeline in oncology and immuno-oncology. We will […]
Apr 8-13
2022
INOVOTION WILL ATTEND THE AACR
Join us at AACR 2022 in New Orleans, April 8 -13! Stop by our Booth #3315 to learn more about our new, efficient, 3R-compliant and cost-effective preclinical models! Meet with Philippe Fornies, our […]
